leisure time -WSS

leisure time

author：Wikipedia 2025-09-30 17:28:08 - browse：4678

Adam's take main illustration — Molly Ferguson/STAT

CHICAGO — Something is off about the way Novartis is talking about pelabresib, its newly acquired and costly treatment for myelofibrosis. I suspect the Swiss pharma giant’s previously stated plan to submit a marketing application to the Food and Drug Administration this year has been blocked.

I’m not just speculating wildly. It’s looking increasingly likely that the $3 billion purchase of MorphoSys to acquire pelabresib — a deal pushed hard by top Novartis executive strategist Ronny Gal over some internal dissent — has run into serious trouble just days after the closing.

On Sunday evening, Novartis Chief Medical Officer Shreeram Aradhye, speaking at the company’s ASCO investor event here in Chicago, offered this response to an analyst who asked about pelabresib.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： The health care issue Democrats can’t solve: hospital reform

Wikipedia

entertainment

WSS

Digital health funding stays low as a new reality sets in

Infant mortality in U.S. rose last year for first time in decades: CDC

Humans aren't the only ones with an imagination. Rats have it too

Digital health funding stays low as a new reality sets in

Live blog: Hearing on CRISPR

Cuban government calls US nuclear submarine stop a 'provocative escalation'

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Lung cancer screening guidelines updated for cigarette smokers

Cancer drug shortages should be causing more outrage

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

ChatGPT in medicine: STAT answers readers' burning questions

Britney Spears to release memoir, 'The Woman In Me,' later this year

Supreme Court strikes down use of affirmative action

What is microchimerism and how does it affect maternal health?

State Dept. review finds Biden bears some blame for Afghanistan failures

Kidney transplant patients stopped immunosuppressants in trial

entertainment

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Blinken talks high

Explaining an after

Vermont grapples with historic flooding as more rainstorms head for Northeast

Kidney transplant patients stopped immunosuppressants in trial

One Duchenne patient's bittersweet hope for new treatment

Wikipedia

leisure time

entertainment

entertainment